Tesamorelin 5mg + MGF 500mcg + Ipamorelin 2.5mg Peptides
Engineered for precision, this tri-peptide blend brings disciplined simplicity to complex GH-axis exploration.
This Tesamorelin, MGF, and Ipamorelin blend is presented as a lyophilized research peptide vial designed for controlled laboratory workflows. The style is a clean, unflavored lyophilized powder, formulated for researchers evaluating growth hormone-related pathways. Active ingredient type: GH peptide blend. Strength: 5mg/500mcg/2.5mg per vial, reflecting the precise amounts of each component.
- 5mg Tesamorelin – A growth hormone–releasing hormone analog referenced in the literature for probing pituitary GHRH receptor signaling and GH-axis dynamics in controlled models.
- 500mcg MGF – The mechano growth factor splice variant of IGF-1, examined for its role in mechano-sensitive signaling and localized IGF-related pathways in investigative settings.
- 2.5mg Ipamorelin – A selective ghrelin/secretagogue receptor agonist used to study pulsatile GH release characteristics and pathway selectivity under rigorously defined conditions.
As a non-edible laboratory compound, this vial is intended for methodological consistency and reproducibility. The lyophilized format supports stability prior to reconstitution, allowing qualified professionals to integrate the blend into established protocols with clear component ratios. Researchers may examine complementary mechanisms—GHRH-receptor activation (Tesamorelin), secretagogue-mediated signaling (Ipamorelin), and IGF-related splice-variant activity (MGF)—within a single, well-defined preparation. When properly handled, the powder reconstitutes to a clear solution appropriate for in vitro or ex vivo experimental designs as determined by the laboratory.
Peptide Scientific Labs is a USA-based supplier committed to rigorous standards. Vials are prepared and filled in controlled environments with careful handling, lot identification, and consistent presentation. Each batch is evaluated to confirm identity and assess purity, supporting dependable results across repeat experiments. Our approach emphasizes transparency, traceability, and quality-first practices so researchers can work with confidence.
For laboratory research only. Not for human consumption, medical use, or veterinary use. This product is not a drug, food, or cosmetic. Use only by qualified professionals in appropriate research facilities, following applicable regulations and institutional guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is TESA/IPA Blend typically studied for?
Researchers generally study this combination for growth-hormone pulse support, IGF-1-related signaling, and body-composition or recovery-oriented endocrine models. The useful nuance for an FAQ is that blends like this are chosen for pathway complementarity, but study relevance still depends on the exact dose ratio disclosed by the vendor.
What is TESA/IPA Blend?
TESA/IPA Blend combines Tesamorelin, a GHRH analog, with Ipamorelin, a ghrelin-receptor agonist. The purpose of the blend is to bring together two different upstream signals that can influence endogenous growth-hormone release. On a site page, it should be described as a research blend for GH-axis and endocrine studies only.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
